| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $51.5M | +34.1% |
| SG&A Expense | $16.5M | +32.6% |
| Operating Income | -$68.1M | -33.7% |
| Pre-tax Income | -$60.1M | -42.3% |
| Income Tax | $0 | — |
| Net Income | -$60.0M | -41.9% |
| EPS (Basic) | -$2.17 | +0.5% |
| EPS (Diluted) | -$2.17 | +0.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.6M | +244.5% |
| Short-term Investments | $187.3M | +2.4% |
| Current Assets | $267.9M | +29.8% |
| Total Assets | $276.6M | +30.0% |
| Current Liabilities | $9.7M | -2.3% |
| Total Liabilities | $15.7M | +5.9% |
| Stockholders' Equity | $261.0M | +31.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.3M | -68.4% |
| Capital Expenditures | $231K | -55.1% |
| Investing Cash Flow | -$3.7M | +94.7% |
| Financing Cash Flow | $112.7M | +3.4% |
| Free Cash Flow | -$55.5M | -66.5% |